200 related articles for article (PubMed ID: 33807701)
1. Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome.
Lester Sequiera G; Srivastava A; Alagarsamy KN; Rockman-Greenberg C; Dhingra S
Cells; 2021 Mar; 10(3):. PubMed ID: 33807701
[TBL] [Abstract][Full Text] [Related]
2. Generation of human induced pluripotent stem cell (hiPSC) line UOMi005-A from PBMCs of a patient with Kearns-Sayre syndrome.
Srivastava A; Lester Sequiera G; Narayan Alagarsamy K; Rockman-Greenberg C; Dhingra S
Stem Cell Res; 2021 May; 53():102283. PubMed ID: 33756177
[TBL] [Abstract][Full Text] [Related]
3. Human induced pluripotent stem cell (hiPSC) line UOMi006-A derived from PBMCs of a patient with Kearns-Sayre syndrome.
Srivastava A; Alagarsamy KN; Sequiera GL; Rockman-Greenberg C; Dhingra S
Stem Cell Res; 2021 May; 53():102355. PubMed ID: 33901817
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA deletion and duplication in Kearns-Sayre Syndrome (KSS) with initial presentation as Pearson Marrow-Pancreas Syndrome (PMPS): Two case reports in Barranquilla, Colombia.
Sabella-Jiménez V; Otero-Herrera C; Silvera-Redondo C; Garavito-Galofre P
Mol Genet Genomic Med; 2020 Nov; 8(11):e1509. PubMed ID: 33030289
[TBL] [Abstract][Full Text] [Related]
5. Kearns-Sayre syndrome case. Novel 5,9 kb mtDNA deletion.
Grigalionienė K; Burnytė B; Balkelienė D; Ambrozaitytė L; Utkus A
Mol Genet Genomic Med; 2023 Jan; 11(1):e2059. PubMed ID: 36181358
[TBL] [Abstract][Full Text] [Related]
6. Are duplications of mitochondrial DNA characteristic of Kearns-Sayre syndrome?
Poulton J; Morten KJ; Weber K; Brown GK; Bindoff L
Hum Mol Genet; 1994 Jun; 3(6):947-51. PubMed ID: 7951243
[TBL] [Abstract][Full Text] [Related]
7. [Mitochondrial DNA mutations in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome].
Wang ZX; Yuan Y; Gao F; Qi Y; Shen DG; Chen QT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):273-8. PubMed ID: 12903032
[TBL] [Abstract][Full Text] [Related]
8. [Mitochondrial DNA deletions in Kearns-Sayre syndrome].
Carod-Artal FJ; Lopez Gallardo E; Solano A; Dahmani Y; Herrero MD; Montoya J
Neurologia; 2006 Sep; 21(7):357-64. PubMed ID: 16977556
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease.
Boles RG; Roe T; Senadheera D; Mahnovski V; Wong LJ
Eur J Pediatr; 1998 Aug; 157(8):643-7. PubMed ID: 9727847
[TBL] [Abstract][Full Text] [Related]
10. Clinical Phenotype and Genetic Features of a Pair of Chinese Twins with Kearns-Sayre Syndrome.
Guo L; Wang X; Ji H
DNA Cell Biol; 2020 Aug; 39(8):1449-1457. PubMed ID: 32609007
[TBL] [Abstract][Full Text] [Related]
11. [Deletions of mitochondrial DNA in Kearns-Sayre syndrome].
Soga F; Ueno S; Yorifuji S
Nihon Rinsho; 1993 Sep; 51(9):2386-90. PubMed ID: 8411717
[TBL] [Abstract][Full Text] [Related]
12. The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy.
Maceluch JA; Niedziela M
Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):117-37. PubMed ID: 17342029
[TBL] [Abstract][Full Text] [Related]
13. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
[TBL] [Abstract][Full Text] [Related]
14. Deletions of mitochondrial DNA in Kearns-Sayre syndrome.
Zeviani M; Moraes CT; DiMauro S; Nakase H; Bonilla E; Schon EA; Rowland LP
Neurology; 1988 Sep; 38(9):1339-46. PubMed ID: 3412580
[TBL] [Abstract][Full Text] [Related]
15. A case of Kearns-Sayre syndrome showing a constant proportion of deleted mitochondrial DNA in blood cells during 6 years of follow-up.
Mohri I; Taniike M; Fujimura H; Matsuoka T; Inui K; Nagai T; Okada S
J Neurol Sci; 1998 Jun; 158(1):106-9. PubMed ID: 9667787
[TBL] [Abstract][Full Text] [Related]
16. Whole sequence of the mitochondrial DNA genome of Kearns Sayre Syndrome patients: Identification of deletions and variants.
Saldaña-Martínez A; Muñoz ML; Pérez-Ramírez G; Montiel-Sosa JF; Montoya J; Emperador S; Ruiz-Pesini E; Cuevas-Covarrubias S; López-Valdez J; Ramírez RG
Gene; 2019 Mar; 688():171-181. PubMed ID: 30528267
[TBL] [Abstract][Full Text] [Related]
17. Duplications of mitochondrial DNA in Kearns-Sayre syndrome.
Poulton J; Morten KJ; Marchington D; Weber K; Brown GK; Rötig A; Bindoff L
Muscle Nerve Suppl; 1995; 3():S154-8. PubMed ID: 7603518
[TBL] [Abstract][Full Text] [Related]
18. Functional consequences of mitochondrial DNA deletions in human skin fibroblasts: increased contractile strength in collagen lattices is due to oxidative stress-induced lysyl oxidase activity.
Majora M; Wittkampf T; Schuermann B; Schneider M; Franke S; Grether-Beck S; Wilichowski E; Bernerd F; Schroeder P; Krutmann J
Am J Pathol; 2009 Sep; 175(3):1019-29. PubMed ID: 19661442
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmoplegia in Mitochondrial Disease.
Lee SJ; Na JH; Han J; Lee YM
Yonsei Med J; 2018 Dec; 59(10):1190-1196. PubMed ID: 30450853
[TBL] [Abstract][Full Text] [Related]
20. Redefining phenotypes associated with mitochondrial DNA single deletion.
Mancuso M; Orsucci D; Angelini C; Bertini E; Carelli V; Comi GP; Donati MA; Federico A; Minetti C; Moggio M; Mongini T; Santorelli FM; Servidei S; Tonin P; Toscano A; Bruno C; Bello L; Caldarazzo Ienco E; Cardaioli E; Catteruccia M; Da Pozzo P; Filosto M; Lamperti C; Moroni I; Musumeci O; Pegoraro E; Ronchi D; Sauchelli D; Scarpelli M; Sciacco M; Valentino ML; Vercelli L; Zeviani M; Siciliano G
J Neurol; 2015 May; 262(5):1301-9. PubMed ID: 25808502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
